Cited by 130Attention Deficit Hyperactivity DisorderBehavioral and Psychological StudiesPharmaceutical studies and practices

A Double-Blind, Placebo-Controlled Study of Adderall and Methylphenidate in the Treatment of Attention-Deficit/Hyperactivity Disorder

PLISZKA, STEVEN R., BROWNE, RONALD G., OLVERA, RENE L., WYNNE, SUSAN K.·2000·Journal of the American Academy of Child & Adolescent Psychiatry

Abstract

Objective While Adderall has been available for the treatment of attention-deficit/hyperactivity disorder (ADHD) for several years, there are few controlled studies comparing it to methylphenidate. Method Fifty-eight children with ADHD (mean age 8.1 +/- 1.4 years) were randomly assigned to receive placebo, methylphenidate, or Adderall in a double-blind, parallel-group design for 3 weeks. Dosage was adjusted at the end of weeks 1 and 2 via an algorithm based on teacher and parent ratings. Final doses were 12.5 +/- 4.1 mg/day for Adderall and 25.2 +/- 13.1 mg/day for methylphenidate. Teacher and parent ratings, as well as the psychiatrist's Clinical Global Impression (CGI), were the final outcome measures at the end of week 3. Results Both medications were superior to placebo at reducing inattentive and oppositional symptoms in the classroom and on the CGI. Adderall produced significantly more improvements on teacher ratings and the CGI than methylphenidate, although the algorithm may have limited dosing in the methylphenidate group. Seventy percent of children in the Adderall group were given medication once a day, compared with 15% of the subjects receiving methylphenidate. Conclusions Adderall compared favorably to methylphenidate, and the behavioral effects of Adderall appear to persist longer than those of methylphenidate after individual doses.

Integrity signals

Registry

Crossref · 10.1097/00004583-200005000-00016

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Exacerbation of irritability is a reported side effect of stimulant treatment.

    “Clinical decision making in regards to emotional lability is complicated by the fact that exacerbation of irritability is a reported side effect of stimulant treatment [42, 43].”

    From Using Stimulants to Treat ADHD-Related Emotional Lability (2014) · cites this paper as [42]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
PLISZKA, S. R., BROWNE, R. G., OLVERA, R. L., & WYNNE, S. K.
Affiliations
The University of Texas at San Antonio Health Science Center (US)
Corresponding author
PLISZKA, STEVEN R.
Venue
Journal of the American Academy of Child & Adolescent Psychiatry
Publisher
Elsevier BV
Published
2000-05
Volume
39
Issue
5
Pages
619-626
ISSN
0890-8567 (ISSN-L)
OpenAlex
W2013550669
Cited by
130
References
1
Citations by year
2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 4 · 2014: 6 · 2013: 2 · 2012: 6
FWCI
6.68
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
Keywords
attention deficit hyperactivity disorder, Adderall, methylphenidate, stimulant medication, children, drug comparison, teacher ratings, parent ratings, Clinical Global Impression Scale, inattentive symptoms, once-daily dosing
MeSH terms
Algorithms, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Double-Blind Method, Female, Humans, Male, Methylphenidate, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review